EMD Serono Appoints CMO
This article was originally published in Scrip
EMD Serono, the US biopharmaceutical business of Merck KGaA., has appointed Joseph Leveque as chief medical officer (CMO). Leveque has over 20 years' experience in strategic leadership roles and medical and clinical programs and has been the medical lead in various biopharmaceutical roles. He joins EMD Serono from Bristol-Myers Squibb where he was head of US medical for oncology. Prior to this, he held medical affairs leadership positions at Onyx Pharmaceutical, Inc., Cephalon and Amgen, Inc.